Suppr超能文献

根据大鼠药代动力学参数预测九种弱酸性和六种弱碱性药物在人体内的处置情况。

Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.

作者信息

Sawada Y, Hanano M, Sugiyama Y, Iga T

出版信息

J Pharmacokinet Biopharm. 1985 Oct;13(5):477-92. doi: 10.1007/BF01059331.

Abstract

Various pharmacokinetic parameters--disposition half-life, t1/2,z, metabolic clearance CLm, volume of distribution V, intrinsic clearance of unbound drug CLuint, and unbound volume of distribution of tissues (distributive tissue volume/fraction of drug in tissue unbound, VT/fuT--are compared in rat and human for nine weakly acidic drugs, phenytoin, hexobarbital, pentobarbital, phenylbutazone, warfarin, tolbutamide, valproate, phenobarbital, and amobarbital, and six weakly basic drugs, quinidine, chlorpromazine, propranolol, pentazocin, antipyrine, and diazepam. With regard to all parameters, statistically significant correlations are obtained when parameters are plotted on a log-log plot. Correlation coefficients between the intrinsic parameters (CLuint or VT/fuT) were higher than those between the hybrid parameters (t1/2,z, CLm or V). In general, these drugs were metabolized ten times more rapidly in rat than in human. With regard to the tissue distribution of these drugs, there was little difference between rat and human. Predictions of CLm, V, and t1/2, in humans using rat data were successful for most drugs, with a few marked exceptions.

摘要

比较了大鼠和人类体内9种弱酸性药物(苯妥英、己巴比妥、戊巴比妥、保泰松、华法林、甲苯磺丁脲、丙戊酸盐、苯巴比妥和异戊巴比妥)以及6种弱碱性药物(奎尼丁、氯丙嗪、普萘洛尔、喷他佐辛、安替比林和地西泮)的各种药代动力学参数——处置半衰期(t1/2,z)、代谢清除率(CLm)、分布容积(V)、游离药物的内在清除率(CLuint)以及组织的游离分布容积(组织分布容积/组织中游离药物分数,VT/fuT)。对于所有参数,当在对数-对数图上绘制参数时,可获得具有统计学意义的相关性。内在参数(CLuint或VT/fuT)之间的相关系数高于混合参数(t1/2,z、CLm或V)之间的相关系数。一般来说,这些药物在大鼠体内的代谢速度比在人类体内快10倍。关于这些药物的组织分布,大鼠和人类之间几乎没有差异。使用大鼠数据预测人类的CLm、V和t1/2,对大多数药物来说是成功的,但有一些明显的例外。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验